Testing for Nitrosation in Patients at Risk of Gastric Cancer
Author Information
Author(s): P.W.J. Houghton, S. Leach, R.W. Owen, N.J. McC. Mortensen, M.J. Hill, R.C.N. Williamson
Primary Institution: University Department of Surgery, Bristol Royal Infirmary
Hypothesis
Can modified N-nitrosoproline testing show increased intragastric nitrosation in patients at risk of gastric cancer?
Conclusion
The study confirmed that patients with hypochlorhydria have increased intragastric nitrosation, which may lead to the formation of carcinogenic compounds.
Supporting Evidence
- Urinary N-nitrosoproline levels were significantly higher in Polya partial gastrectomy patients compared to controls.
- Post-vagotomy patients also showed increased urinary N-nitrosoproline levels compared to controls.
- Patients with pernicious anaemia had higher N-nitrosoproline levels than controls, but it was not statistically significant.
Takeaway
Doctors tested urine to see if certain patients had higher levels of a chemical that could lead to stomach cancer, and they found that some patients did.
Methodology
The study involved measuring urinary N-nitrosoproline levels after administering sodium nitrate and L-proline to patients and controls.
Potential Biases
Patient selection ensured a similar number of smokers in each group, but smoking may still influence results.
Limitations
The study could not determine the variability of the test due to ethical concerns about frequent testing on patients.
Participant Demographics
The study included 11 controls and 35 patients, with various gastric conditions including vagotomy, partial gastrectomy, and pernicious anaemia.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website